Literature DB >> 6231144

Hyperglobulinaemia in chronic liver disease: relationships between in vitro immunoglobulin synthesis, short lived suppressor cell activity and serum immunoglobulin levels.

P B Rong, J Kalsi, H J Hodgson.   

Abstract

In a group of patients with chronic liver diseases (CLD), including both chronic active hepatitis of 'immunological' type and alcoholic cirrhosis, simultaneous measurements were made of serum immunoglobulin levels, in vitro synthesis of immunoglobulin by peripheral blood mononuclear cells, and in vitro short lived suppressor cell activity. In both forms of CLD, decreased short lived suppressor cell activity was found. There was a strong linear correlation between the amount of IgG released into supernatant of 7 day in vitro cultures and the serum IgG levels amongst patients with CLD. There was also a strong inverse correlation in the patient group between in vitro synthesis of IgG and IgA and the suppressor cell activity measured in the same cell population, suggesting that the short lived suppressor cell test may reflect activity of cells modulating immunoglobulin both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231144      PMCID: PMC1535931     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Alteration in suppressor cell activity in chronic active hepatitis.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  In vitro thymosin effect on T lymphocytes in alcoholic liver disease.

Authors:  M G Mutchnick; A L Goldstein
Journal:  Clin Immunol Immunopathol       Date:  1979-03

3.  Hyperglobulinaemia in liver disease.

Authors:  D R Triger; R Wright
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

4.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

5.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

6.  Antibodies to Escherichia coli in chronic liver diseases.

Authors:  A E Simjee; J M Hamilton-Miller; H C Thomas; W Brumfitt; S Sherlock
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

7.  Immune function in patients with extrahepatic portal venous obstruction and the effect of splenectomy.

Authors:  L J Webb; M Ross; R L Markham; A D Webster; H C Thomas; S Sherlock
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

8.  Liver disease--a prominent cause of serum IgE elevation.

Authors:  E Van Epps; G Husby; R C Williams; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

9.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

10.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

View more
  2 in total

1.  Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes.

Authors:  L S Milner; M T Houser; P C Kolbeck; D L Antonson; T L McDonald; R S Markin; B W Shaw
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

2.  Helper and suppressor T lymphocyte function in severe alcoholic liver disease.

Authors:  U McKeever; C O'Mahony; C A Whelan; D G Weir; C Feighery
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.